The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: 0.50 (1.44%)
Spread: 0.50 (1.429%)
Open: 34.75
High: 35.50
Low: 35.25
Prev. Close: 34.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Feb 2010 07:00

RNS Number : 7246G
China Real Estate Opportunities PLC
05 February 2010
 



 

 

 

China Real Estate Opportunities plc

 

Pre-Close Trading Update

 

China Real Estate Opportunities plc (the "Company"), one of the leading Chinese property companies quoted on the AIM market of the London Stock Exchange, has issued the following trading update in advance of the release of its annual results for the 12 month period ended 31 December 2009.

 

Property Portfolio Valuation as at 31 December 2009

 

The Board is pleased to announce that as at 31 December 2009 the aggregate gross value of the portfolio, as determined by an independent valuation carried out by DTZ Debenham Tie Leung in accordance with RICS standards, was RMB9.188 billion (equivalent to £837 million at the closing exchange rate of RMB10.98:£1 as at 31 December 2009). These valuations are broken down as follows:

 

Name

31 December 2009

30 June 2009

RMB million

RMB million

City Centre, Shanghai

5,564

5,390

City Centre Extension, Shanghai

1,261

1,213

Central Plaza, Shanghai

1,604

1,532

The Treasury Building, Shanghai

641

600

Beijing International Logistics Centre, Beijing

118

 

99

Total

9,188

8,834

 

These valuations, which are based on fair values in accordance with the Company's normal accounting policies, represent an increase of 4% in local currency terms (7.35% in sterling terms) since the 30 June 2009 valuation of RMB8.834 billion (equivalent to £780 million at the then prevailing exchange rate of RMB11.25:£1). These amounts exclude the recent disposal of the Company's interest in the Tangdao Bay property, the proceeds of which will be received upon completion of the standard PRC regulatory procedures for the offshore repatriation of proceeds of domestic asset sales.

 

Trading Update

The year just ended proved to be a challenging year on the office leasing front with vacancy rates in Shanghai peaking at 14.2% in Q1 and reducing to 11.4% by year end. The retail sector however, continued to perform strongly, aided by the resurgence of the Chinese consumer.

 

The property portfolio witnessed 212 lease expiries during the year, representing more than 50% of its entire tenancy base. Approximately 55% of these leases were renewed, whilst a further 15% were moved out of the Central Plaza property as part of the refurbishment and re-positioning program. Sixty new tenants, amounting to 28% of lease expiries, entered into leases including Metlife Insurance, Prudential Insurance and Johnson & Johnson. Overall, this resulted in portfolio occupancy (excluding space under refurbishment) at 31 December 2009 of 85%, (office 79%; retail 97%) representing a reduction of 6% over 31 December 2008 but translated into increases in gross rental income on a per square metre basis as follows:

 

Average daily rent per sqm (RMB)

Investment Property

31 December 2009

30 June 2009

Increase over period

City Centre Office

5.32

5.05

5%

City Centre Retail

6.11

5.97

2%

Central Plaza

6.33

6.16

3%

Treasury Building

6.18

6.18

0%

 

As previously reported, during the year, two disposals have been made at premia to the values at which they had been included in the financial statements. These were the 5% interest in City Centre 5, disposed of in June 2009 for an 8.9% premium over the valuation at 31 December 2008 and the 50% interest in Tangdao Bay, disposed of in January 2010 for a 10.9% premium over the valuation at 30 June 2009. In addition, the disposal in November 2009 of approximately 60% of the Company's shareholding in RREEF China Commercial Trust, a Hong Kong listed entity, generated a 20% return on acquisition price.

 

Including the proceeds from the Tangdao Bay disposal, the Company's cash holdings at 31 December 2009 would have amounted to approximately £75 million.

 

The Company also made significant progress in the first phase of its refinancing programme with the completion of a loan facility with CITIC Ka Wah Bank in December 2009. This replaced, on improved terms, the existing loan with Credit Suisse in respect of the Treasury Building in Shanghai, which had been due to expire in March 2010. From discussions taking place, the Company remains confident that significant interest remains from a number of local and regional banks to fulfill the Company's refinancing requirements in 2010.

 

 Asian listing

Despite this strong performance in a difficult global environment, the Company's shares continue to trade at a significant discount to net asset value. With a view to narrowing the gap, the Board, with its advisers, has been considering for some time a number of options intended to widen the universe of potential shareholders, including obtaining a listing for the Company on a recognised stock exchange in Asia, so as to deliver the following potential benefits:

 

Ø Positioning the company closer to its asset base

Ø Strong regional appreciation for Chinese real estate companies which in the main trade at a very low discount or slight premium to NAV

Ø Ability to participate in the strong capital flows experienced in Asia, which have exceeded USD8.8 billion for the property sector on the Hong Kong and Singapore exchanges alone in the past 6 months

 

More specifically, the Board has identified Singapore as its preferred listing location and a "Business Trust" structure under Singapore law as the likely structure, and subject to ongoing communication with shareholders and the relevant regulators, the Company intends to proceed with this proposal within the next 6 months.

 

Singapore Business Trusts provide greater operational and investment flexibility than Real Estate Investment Trusts with regard to matters such as development limits and levels of gearing. This flexibility should enable CREO to deliver stronger growth and higher accretive earnings than its peer group.

 

The Company intends to engage with its shareholders to elicit their feedback on this proposal, which is at an advanced exploratory stage.

 

Tender Offer

The Company expects to receive the sales proceeds from its disposal of Tangdao Bay upon completion of the standard PRC regulatory procedures for the offshore repatriation of proceeds of domestic asset sales and CREO will make a further announcement regarding the proposed tender offer in due course.

 

Contact:

 

CREO

Ray Horney, Chairman

Tel: + 44 (0)1273 775225

 

Sarah Moriarty, Investor Relations

Tel: +353 1 6189455

 

Matrix Corporate CapitalPaul Fincham Tel +44 (0)20 3206 7000

Davy

Des Carville

Tel: +353 1 679 6363

 

Citigate Dewe Rogerson Limited

Tom Baldock

Tel: + 44 (0) 20 7638 9571

 

Murray Consultants

Ed Micheau

Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKQDNOBKDKBK
Date   Source Headline
13th May 20247:00 amRNSDirectorate Changes
7th May 20247:00 amRNSCreo Medical receives King’s Award for Enterprise
25th Apr 20247:00 amRNSNotice of Results
24th Apr 20247:00 amRNSNHS Speedboat data demonstrates savings
20th Mar 20244:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSWelsh Labour Leader visits Creo’s facilities
13th Mar 20243:05 pmRNSHolding(s) in Company
11th Mar 20242:00 pmRNSLTIP Awards
6th Mar 20244:35 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSMicrowave Lung Ablation Update
7th Feb 20249:12 amRNSTrading Update - Replacement
7th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSStrategic Collaboration with Khalifa University
31st Jan 20247:00 amRNSSpeedboat® UltraSlim roll-out reaches Asia Pacific
22nd Jan 20247:00 amRNSAward of Shares under Share Incentive Plan
10th Jan 20247:00 amRNSFirst use of Speedboat® UltraSlim in Latin America
15th Dec 20237:00 amRNSFirst use of Speedboat® UltraSlim in the USA
13th Dec 20237:00 amRNSFirst European Speedboat® UltraSlim procedure
7th Nov 20237:00 amRNSCapital Markets Day
1st Nov 20237:00 amRNSSpeedboat® UltraSlim: US FDA Clearance
25th Oct 20237:00 amRNSSB UltraSlim: EU launch accelerated by 18 months
16th Oct 202310:16 amRNSChange of Nominated Adviser and Joint Broker
12th Oct 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results
16th Aug 20237:00 amRNSRoyal Oldham SSD service update
3rd Aug 20237:00 amRNSHalf Year Trading Update
28th Jul 20237:00 amRNSTotal Voting Rights
24th Jul 202310:40 amRNSAward of Shares under Share Incentive Plan
6th Jul 202311:33 amRNSIssue of Equity and TVR
27th Jun 20231:15 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement & Directorate Succession Planning
26th Jun 20237:00 amRNSFirst upper GI Speedboat procedure in Europe
22nd Jun 20237:00 amRNSAppointment of Marco Scarci
19th Jun 20237:00 amRNSSpeedboat Inject upper GI clearance in Europe
1st Jun 20237:00 amRNSSpeedboat™ Inject selected by NICE for assessment
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
23rd May 20237:00 amRNSFirst in-human milestone for MicroBlate™ Flex
17th May 20237:00 amRNSRoyal Oldham Hospital Agreement
15th May 20237:00 amRNSAttendance at Digestive Disease Week
26th Apr 20237:00 amRNSFinal Results
14th Apr 20237:00 amRNSAlbyn Medical earn out update
31st Mar 202310:45 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSMicroBlate™ Flex clinical study
13th Mar 20236:13 pmRNSDirector/PDMR and PCA Share Dealings
13th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 202310:25 amRNSResult of GM
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
21st Feb 202310:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.